Rational symptomatic therapy for chronic pruritus;Rationelle symptomatische therapie bei chronischem pruritus

Hautarzt

Volumn 57, Issue 5, 2006, Pages 403-410

  Stander S ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antipruritic therapy; Cannabinoids; Itch; Prurigo; Pruritus

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIPRURITIC AGENT; AZELASTINE; CALCINEURIN INHIBITOR; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; CETIRIZINE; CLEMASTINE FUMARATE; CLOBETASOL; CORTICOSTEROID; CYCLOSPORIN A; DESLORATADINE; DIFLUCORTOLONE; DIMETINDENE; FEXOFENADINE; GABAPENTIN; HYDROXYZINE; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LORATADINE; METHYLPREDNISOLONE; MOMETASONE FUROATE; MONTELUKAST; NALTREXONE; NEUROLEPTIC AGENT; PIMECROLIMUS; TACROLIMUS; UNINDEXED DRUG;

ARTICLE; CORTICOSTEROID THERAPY; HEALTH CARE COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAST CELL; PALLIATIVE THERAPY; PHOTOTHERAPY; PRURIGO; PRURITUS; PSYCHOSOMATIC DISORDER; SKIN DISEASE; SYSTEMIC DISEASE;

AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PRURITUS;

EID: 33646544676     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-006-1123-x     Document Type: Article

References (24)

1. Amsellem C, Czarlewski W, Lagarde M, Pacheco Y (1998) Inhibitory effect of loratadine on leukotriene B4 production by neutrophils either alone or during interaction with human airway epithelial cells. Pulm Pharmacol Ther 11: 245-252
2. Andoh T, Kuraishi Y (2002) Inhibitory effects of azelastine on substance P-induced itch-associated response in mice. Eur J Pharmacol 436: 235-239
3. Biondi M, Arcangeli T, Petrucci RM (2000) Paroxetine in a case of psychogenic pruritus and neurotic excoriations. Psychother Psychosom 69: 165-166
4. Brune A, Metze D, Luger TA, Ständer S (2004) Antipruritische Therapie mit dem oralen Opiatrezeptorantagonisten Naltrexon: offene, nicht-placebo-kontrollierte Anwendung bei 133 Patienten. Hautarzt 55: 1130-1136
5. Edmonds EV, Riaz SN, Francis N, Bunker CB (2004) Nodular prurigo responding to topical tacrolimus. Br J Dermatol 150: 1216-1217
6. Gralow I (2002) Pharmakologische Therapie. In: Gralow I, Husstedt IW, Bothe HW et al. (Hrsg) Schmerztherapie interdisziplinär. Schattauer, Stuttgart New York, S 318-319
7. Manenti L, Vaglio A (2004) Gabapentin for uraemic pruritus. Nephrol Dial Transplant 19: 3137-3139
8. Reimann S, Luger T, Metze D (2000) Topische Anwendung von Capsaicin in der Dermatologie zur Therapie von Juckreiz und Schmerz. Hautarzt 51: 164-172
9. Schneider G, Gieler U (2001) Die Haut als Spiegel der Seele. Psychosomatische Dermatologie - aktueller Forschungsstand. Z Psychosom Med Psychother 47: 307-331
10. Schürmeyer-Horst F, Fischbach R, Nabavi D et al. (2006) Brachioradialer Pruritus: eine seltene, lokalisierte, neuropathische Juckreizform. Hautarzt (im Druck)
11. Ständer S, Luger T, Metze D (2001) Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 44: 471-478
12. Ständer S, Luger TA (2003) Antipruritische Wirkung von Pimecrolimus und Tacrolimus. Hautarzt 54: 413-417
13. Ständer S, Schmelz M, Metze D et al. (2004) Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory and autonomic nerve fibers and appendage structures in human skin. J Invest Dermatol 123: A91
14. Ständer S, Metze D (2004) Treatment of pruritus in internal and dermatological diseases with opioid receptor antagonists. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F (eds) Itch: basic mechanisms and therapy. Marcel Dekker, New York Basel, pp 259-277
15. Ständer S, Schürmeyer-Horst F, Luger TA, Weisshaar E (2006) Treatment of pruritic diseases with topical calcineurin inhibitors. Therapeutics and Clinical Risk Management. (in press)
16. Ständer S, Streit M, DarsowU et al. (2006) Leitlinie: Diagnostisches und therapeutisches Vorgehen bei chronischem Pruritus. J Dtsch Dermatol Ges (im Druck)
17. Tefferi A, Fonseca R (2002) Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood 99: 2627
18. Temple DM, McCluskey M (1988) Loratadine, an anti-histamine, blocks antigen- and ionophore-induced leukotriene release from human lung in vitro. Prostaglandins 35: 549-554
19. Torres-Alvarez B, Castanedo-Cazares JP, Moncada B (2004) Pentoxifylline in the treatment of actinic prurigo. A preliminary report of 10 patients. Dermatology 208: 198-201
20. Valsecchi R, di Landro A, Pansera B, Cainelli T (1994) Contact dermatitis from a gel containing dimethindene maleate. Contact Dermatitis 30: 248-249
21. Woodmansee DP, Simon RA (1999) A pilot study examining the role of zileuton in atopic dermatitis. Ann Allergy Asthma Immunol 83: 548-552
22. Yesudian PD, Wilson NJ (2005) Efficacy of gabapentin in the management of pruritus of unknown origin. Arch Dermatol 141: 1507-1509
23. Zabawski EJ Jr, Kahn MA, Gregg LJ (1999) Treatment of atopic dermatitis with zafirlukast. Dermatol Online J 5: 10
24. Zylicz Z, Smits C, Krajnik M (1998) Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage 16: 121-124